The β 2 integrin (CD 18/CD 11 a, b, c) family of proteins mediate adherence of leukocytes to vascular endothelium and the associated ligand, intercellular adhesion molecule-1 (ICAM-1; CD 54), interacts with β 2 integrin proteins to allow transendothelial migration of leukocytes into sites of inflammation. The present study examines the function of these proteins in a murine model of acute cutaneous inflammation induced following topical application of 12-O-tetradecanoylphorbol-13-acetate (TPA) to the dorsal epidermis of SENCAR mice and in a model of skin multistage carcinogenesis. At 24 h following topical application of TPA to the dorsal epidermis of mice, dermal leukocytes expressed higher levels of β 2 integrin protein compared with the lower levels of β 2 integrin protein expression by peripheral blood leukocytes. ICAM-1 protein was localized to epidermal keratinocytes and vascular endothelium in TPA-treated skin and to proliferating papilloma cells. Intravenous (i.v.) injection of either 50 µg anti-β 2 integrin antibody alone or in combination with anti-ICAM-1 antibody significantly inhibited both TPA-stimulated neutrophil infiltration into the dermis (P < 0.001) and myeloperoxidase (MPO) activity (P < 0.03 anti-β 2 integrin antibody; P < 0.01 anti-β 2 integrin ⍣ ICAM-1 adhesion molecule antibodies), but had no effect on TPA-induced epidermal hyperplasia. In addition, injection of either anti-ICAM-1 adhesion molecule antibody alone (P < 0.004) or in combination with anti-β 2 integrin antibody (P < 0.001) significantly inhibited TPA-induced production of 7,8-dihydroxy-2Ј-deoxyguanosine (8-OHdG) immunoreactive proteins by epidermal keratinocytes. β 2 Integrin/ICAM-1 adhesion molecules work in concert to regulate migration, retention and functional activation of leukocytes within the dermis during TPA-induced skin inflammation and within stromal tissue of papillomas that form during multi-stage carcinogenesis. Agents that inhibit these receptor/ligand interactions may be useful in defining the roles of specific cell populations in cutaneous inflammation and multi-*Abbreviations: DMBA, 7, anthracene; FITC, fluorescein isothiocyanate; ICAM-1, intercellular adhesion molecule-1; IFN-γ, interferon gamma; IL-1, Interleukin-1; LFA-1, lymphocyte function associated antigen-1; MPO, myeloperoxidase; PBS/g, phosphate buffered saline and 0.1% gelatin; TPA, 12-O-tetradecanoylphorbol-13-acetate; TNF-α, tumor necrosis factoralpha; 8-OHdG, 7,8-dihydroxy-2Ј-deoxyguanosine.
Introduction
Topical treatment of murine dorsal epidermis with 12-Otetradecanoylphorbol-13-acetate (TPA*) results in a cutaneous inflammatory response characterized by a dose-and timedependent infiltration of activated leukocytes into the dermis and epidermal hyperplasia (1) (2) (3) (4) (5) . Transendothelial migration of leukocytes from the peripheral circulation and marginal pools into sites of inflammation occurs via surface receptors present on leukocytes that bind to complementary ligands present on vascular endothelium. The molecules present on the plasma membrane of inflammatory leukocytes belong to the β 2 subclass of the integrin supergene family, which is also called the CD-18 or lymphocyte function associated (LFA-1) family of molecules (6, 7) . There are three distinct surface glycoproteins in the β 2 integrin family of molecules, which consist of a unique, variable alpha subunit, i.e. LFA-1 (CD 11a), Mac-1 (CD 11b) and p150, 95 (CD 11c), and a common beta subunit, designated as β 2 integrin (CD 18). The ligands for the β 2 integrin family of molecules are intracellular adhesion molecule-1 (ICAM-1), ICAM-2 and ICAM-3 (8) (9) (10) (11) . ICAM-1 (CD 54) is the molecule primarily involved in interactions with β 2 integrins during inflammatory responses and is present on a wide variety of cell types. Under homeostatic conditions, ICAM-1 expression is low; however, exposure to inflammatory stimuli, such as Interleukin-1 (IL-1), interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) induces high levels of ICAM-1 expression by dermal endothelial cells and epidermal keratinocytes (12, 13) . Studies performed in our laboratory have demonstrated that IL-1α and TNF-α are synthesized by both epidermal keratinocytes and dermal leukocytes during tumor promotion (14) (15) (16) , which suggests that these soluble mediators are present within the local cutaneous environment and could serve as inflammatory stimuli for upregulation of expression of β 2 integrin/ICAM-1 adhesion molecules during murine multi-stage skin carcinogenesis.
In vitro studies have demonstrated that adherence of neutrophils to vascular endothelium and the subsequent transendothelial migration of leukocytes into tissues, as well as adherence of leukocytes to epidermal keratinocytes, are mediated by interactions between members of the β 2 integrins and ICAM-1 molecules (17) . Nickoloff et al. (18) observed that in vitro exposure of cultured human epidermal keratinocytes to TPA enhanced binding of peripheral blood mononuclear leukocytes and that pre-treatment of these cells with anti-LFA-1 antibodies inhibited the adhesion of leukocytes to keratinocytes. In a rabbit model of lung inflammation, Barton et al. (19) showed that the combination of anti-ICAM-1 and anti-LFA-1 (CD 11a/ CD 18) antibodies significantly inhibited neutrophil infiltration into the pulmonary tissue induced by intratracheal instillation of TPA. Antibodies directed against ICAM-1 and LFA-1 molecules have been shown to inhibit renal and cardiac allograft rejection (20, 21) , and also to enhance acceptance of skin grafts (21) . Injection of antibodies directed against LFA-1 and ICAM-1 inhibited contact sensitivity reactions in the skin, as measured by decreases in both edema and cellular infiltration (22) . The results of these previous studies suggest that expression of β 2 integrin/ICAM-1 adhesion molecules may be critical to the inflammatory response that occurs during the tumor promotion process, which has as one of its initial characteristics the extensive infiltration of leukocytes into the dermis (2, 3) . The present studies examined the cell-specific localization of β 2 integrin/ICAM-1 adhesion molecules in cutaneous tissue at the time of the maximal inflammatory response following topical application of either 2 µg or 10 µg TPA (24 h) to the dorsal epidermis of SENCAR mice and in papillomas that developed in SENCAR mice at 16 weeks after a single topical treatment of 25 nmol 7,12-dimethylbenz[a]anthracene (DMBA) followed by twice weekly topical applications of 2 µg TPA. The present studies also determined the extent to which injection of antibody directed against either the individual α subunits or the common β subunit of the β 2 integrin family of molecules, or antibody directed against ICAM-1 (CD 54) adhesion molecules, inhibited parameters that have been used to define TPA-induced cutaneous inflammation, including neutrophil infiltration into the dermis, production of myeloperoxidase (MPO) as a measure of reactive oxygen intermediates, and formation of oxidative DNA base modifications.
Materials and methods

Treatment of animals
For all studies, dorsal hair was shaved from female SENCAR mice (5-8 weeks of age; average wt 30 g; DCT Biological Testing, Frederick, MD) at least 24 h prior to commencement of the studies. Mice treated topically with 0.2 ml acetone served as the vehicle control animals. DMBA (Sigma Chemical Co, St Louis, MO) was dissolved in acetone and mice were treated topically with a final concentration of 25 nmol DMBA in 0.2 ml acetone. TPA (LC Services, Woburn, MA), at a final concentration of either 2 µg or 10 µg, was 446 dissolved in reagent grade acetone and applied in a volume of 0.2 ml to the dorsal epidermis of SENCAR mice. Antibodies directed against β 2 integrin (CD 18), ICAM-1 (CD 54), and the isotypic control hamster IgG and rat IgG2 a antibodies were purchased from Pharmingen (San Diego, CA). Antibodies directed against the alpha subunits of the β 2 integrin family of molecules, LFA-1 (CD 11a), Mac-1 (CD 11b) and p150, 95 (CD 11c) were purchased from Immunotech (Westbrook, ME). At 1 h prior to TPA treatment, mice were injected using the intraperitoneal (i.p.) route of administration, or by the intravenous (i.v.) route of administration with antibody directed against each of the three alpha subunits of the β 2 integrin family of molecules, LFA-1 (CD-11a), MAC-1 (CD-11b), p150,95 (CD-11c), the β 2 integrin subunit (CD-18) or ICAM-1 (CD 54) adhesion molecules at concentrations of 25 µg, 50 µg or 100 µg in 0.2 ml PBS. To control for the effects of injection of foreign proteins, isotypic control IgG antibodies were injected into groups of mice using the same concentration of antibody as was used for injection of the antibodies directed either against the subunits of the β 2 integrin family of proteins or ICAM-1 adhesion molecules. Initial studies determined that the optimal response was observed using the intravenous (i.v.) route of administration and that the optimal dose of antibody was 50 µg/30 g mouse. SENCAR mice were given a single i.v. injection of either 50 µg IgG isotypic antibody in 0.2 ml sterile PBS, or 50 µg of antibodies directed against β 2 integrin (CD 18), LFA-1 (CD 11a), Mac-1 (CD 11b), p150, 95 (CD 11 c), ICAM-1 or the combination of anti-β 2 integrin ϩ anti-ICAM-1 antibodies followed at 1 h later by a single topical application of either 2 µg TPA, 10 µg TPA or acetone. At 24 h following topical treatment of the dorsal epidermis with TPA, mice were euthanized with ether, skin thickness was measured using calipers, cutaneous tissue was divided and used either for MPO analysis, which was performed immediately using freshly isolated tissue, or for histological analysis, which was fixed in neutral buffered formalin for 2 h and then processed as described below, or placed in OCT embeddment medium, snap frozen in liquid nitrogen and used for immunochemical localization studies. Papillomas from mice initiated with a single topical application of 25 nmol DMBA and subsequently treated topically twice weekly with 2 µg TPA for 16 weeks were isolated at 4 h after the final topical application of TPA.
Isolation of peripheral blood leukocytes
Whole blood was obtained by sinus orbital sampling, as previously described (4) . Approximately 1 ml of whole blood was obtained from each animal and immediately added to 30 ml of ice-cold calcium and magnesium-free PBS. Cells were then washed twice with PBS and peripheral blood leukocytes were obtained following lysis of red blood cells with a buffer containing 0.83 M NH 4 Cl, 0.1% KHCO 2 and 0.004% EDTA.
Flow cytometric analysis
Peripheral blood leukocytes were isolated as described above, adjusted to a concentration of 10 6 cells/ml and incubated for 30 min at 4°C with a 1:100 dilution of specific rat anti-mouse β 2 integrin antibody, which was directly conjugated to fluorescein isothiocyanate (FITC) (rat IgG 2a isotype) in PBS containing 0.1% gelatin (PBS/g). The cells were then washed three times in PBS/g and analyzed by flow cytometry. To determine the amount of nonspecific antibody binding, control cells were incubated with IgG 2a isotypic control antibody, which was directly conjugated to FITC. Cells were analyzed for immunofluorescence using a Coulter Elite Flow Cytometer. Optical alignment of the flow cytometer was performed using alignment particles and coefficients of variation for forward laser light scatter and integrated green fluorescence were routinely Ͻ2. For each analysis, both linear and log intensities of green fluorescence were collected and at least 10 000 gated events were accumulated. The data are expressed as intensity of log green fluorescence using a 4 decade log scale.
Immunohistochemistry using cryostat tissue sections
Tissue samples (1 cm 2 ) were isolated from the dorsal epidermis of SENCAR mice at 24 h following topical application of either 0.2 ml acetone, 2 µg TPA or 10 µg TPA, or from mice that were isolated at 16 weeks after a single topical application of 25 nmol DMBA followed by twice weekly applications of 2 µg TPA. Tissues were embedded in OCT embeddment medium, and snap frozen in liquid nitrogen. Sections (6 µm) were cut on a SLEE MTC cryostat and mounted on poly-L-lysine coated microscope slides. The slides were air dried for 1 h, fixed in cold acetone for 15 min, washed in deionized water for 5 min, and then transferred to cold 0.1 M phosphate buffer for 10 min. Hamster anti-murine ICAM-1 antibody, rat anti-murine LFA-1 (CD 11a) antibody, or rat anti-murine Mac-1 (CD 11b) antibodies were incubated at a dilution of 1:50 with tissue sections for 2 h at 25°C. To determine the extent of non-specific binding, hamster anti-mouse IgG or rat anti-mouse IgG 2b were used as isotypic control antibodies. Sections were then washed in 0.1 M phosphate buffer and incubated for 1 h at 25°C with either normal goat serum or rabbit serum. Excess serum was drained from the sections, biotinylated β 2 Integrin/ICAM-1 adhesion molecules in tumor promotion secondary goat anti-hamster or rabbit anti-rat antibody was added and incubated for 1 h at 25°C. Endogenous peroxidase activity was quenched using a solution of 0.3% hydrogen peroxide in 0.1 M phosphate buffer incubated with the tissue sections for 30 min at 25°C in the dark. Slides were washed in 0.1 M phosphate buffer and then incubated for 30 min at 25°C with a horseradish peroxidase conjugated avidin complex. The sections were washed with 0.1 M phosphate buffer and incubated with the chromogen 3,3Ј-diaminobenzidine for 10 min at 25°C. Sections were washed with 0.1 M phosphate buffer for 5 min, then washed in deionized water for 5 min and counterstained with Harris' acid hematoxylin stain. Slides were dehydrated, mounted, viewed and photographed. Immunohistochemistry using paraffin embedded tissue sections Tissue samples (0.5 cm 2 ) were isolated at the time points described above, processed, embedded in paraffin, sectioned at 4 µm sections, mounted on glass slides, and stained with either hematoxylin and eosin for histological analysis, with anti-Gr-1 specific antibody to identify tissue fixed neutrophils, or stained with anti-8-OHdG antibody to identify cells containing oxidative DNA adducts. Gr-1 is a monoclonal antibody directed against a mouse myeloid differentiation antigen that is present on the surface of all neutrophils in tissue but is not present on lymphoid or erythroid cells (23, 24) . The rat anti-mouse Gr-1 (Pharmingen, San Diego, CA) was incubated with tissue sections at a 1:400 dilution and the isotypic control antibody used for the Gr-1 studies to determine the specificity of the Gr-1 antibody binding was IgG 1k (Pharmingen). Quantitation of infiltrating neutrophils within the dermis was based on enumerating Gr-1 ϩ cells within 10 high power (60ϫ) fields, using computer-assisted image analysis, as previously described (16) . For detection of cells that stained with anti-8-OHdG antibodies, tissue sections were deparaffinized using Histo-clear (National Diagnostics; Atlanta, GA) and then rehydrated in a graded series of alcohols with a final wash in distilled water. This protocol used the Microprobe Manual Staining System (Fisher Scientific). Following rehydration, tissue sections were incubated in 2 N HCl at 60°C for 20 min, followed by a rinse in cold 0.1 M Borax buffer and Automation buffer (Biomedia Corp., Foster City, CA). Non-specific antibody binding was blocked by incubating the tissue for 30 min at 25°C in 10% normal horse serum (Vector Burlingame, CA). Mouse ascites anti-8-OHdG (Pharmingen, San Diego, CA; 1:1000 dilution) were placed on the tissue for 90 min at 25°C. Isotypic control IgG 2b antibody (Pharmingen) was used to determine the extent of non-specific antibody binding. After rinsing, tissues were incubated in biotinylated horse anti-mouse secondary antibody (Vector, 1:400 dilution) for 30 min. Following another rinse, avidin/biotinylated horseradish peroxidase complex (ABC Elite, Vector) was placed on the tissue for 30 min at 25°C. After a final buffer rinse, the chromagen, 3,3Ј-diaminobenzidine (DAB) (St Louis, MO) was placed on tissues for 3 min. DAB development was stopped by washing in distilled water. The tissues were counterstained with Harris' hematoxylin (Shandon, Pittsburgh, PA) for 1 min, and then dehydrated, viewed, and photographed.
Detection of myeloperoxidase (MPO)
MPO has been used as an enzymatic marker to quantitate the production of reactive oxygen intermediates by neutrophils that have infiltrated into the skin in response to topical application of tumor promoters (16, (25) (26) (27) . To detect MPO activity in tissue, dorsal skin was isolated from euthanized SENCAR mice at 24 h following i.v. injection with anti-β 2 integrin antibody, anti-ICAM-1 adhesion antibody alone, or in combination with anti-β 2 integrin antibody or the isotypic control antibodies followed at 1 h later by topical application of either 2 µg TPA, 10 µg TPA or acetone. Skin thickness was measured using calipers and dorsal skin was then removed using alcohol cleansed scissors. Skin punches were obtained using a 10-mm diameter cork borer and tissues were weighed. Individual tissue samples were then placed in a solution of 1.25 ml of 0.5% hexadecyltrimethylammonium bromide (HTAB) in 50 mM phosphate buffer, pH 6.0, homogenized at 4°C, subjected to three cycles of sonication and freeze-thawing, and centrifuged for 30 min at 14 000 r.p.m. Supernatants were then transferred to new tubes and 10-µl samples were placed into individual wells of 96-well microtiter plates At 24 h after a single topical application of 10 µg TPA, there was significant ICAM-1 protein expressed by epidermal keratinocytes and dermal fibroblasts (A, 60ϫ magnification) and by vascular endothelial cells (B, 60ϫ magnification). There was no detectable ICAM-1 protein present in skin isolated from SENCAR mice treated topically with acetone (C, 60ϫ magnification). There were significant numbers of leukocytes within the dermis of skin isolated at 24 h following topical application of 10 µg TPA that bound anti-LFA-1 (CD 11a) antibodies (D). Tissue isolated from TPA-treated mice was incubated with isotypic control IgG 2b antibodies to show the specificity of the LFA-1 antibody localization (E, 60ϫ magnification). ICAM-1 protein was present at high levels in papillomas, which was localized to the proliferative compartment (F, 40ϫ magnification) and was present on the microvascular endothelium (G, 60ϫ magnification). Leukocytes contained within the stroma of papillomas that had developed at 16 weeks following a single exposure to 25 nmol DMBA followed by twice weekly treatment with 2 µg TPA, expressed high levels of both LFA-1 (CD 11a) protein (H, 40ϫ magnification) and Mac-1 (CD 11b) protein (I, 60ϫ magnification). The specificity of the LFA-1 and Mac-1 protein staining was determined by the lack of isotypic control antibody binding (J, 60ϫ magnification).
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containing 290 µl of substrate (0.167 mg/ml o-dianisidine dihydrochloride, 0.0005% H 2 O 2 in 50 mM potassium phosphate buffer pH 6.0). MPO activity was measured spectrophotometrically at 450 nm over 5 min using a programmable Molecular Devices microplate reader. Data are expressed as mean Units of MPO activity, where 1 Unit of enzyme activity is defined as the amount of MPO that degrades hydrogen peroxide in 1 min at 25°C. Quantitation of proliferation by autoradiography Methods used to identify cells incorporating [methyl-3 H]thymidine in TPAtreated murine skin were as previously described (14) . Two mice in each treatment group were injected i.p. with 30 mCi/mmol [methyl-3 H]thymidine (70-90 Ci/mmol) in 0.5 ml PBS at 1 h prior to sacrifice. Tissue was isolated, processed, embedded, sectioned on slides, coated with NTB-2 emulsion, exposed and developed. Coverslips were mounted onto wet slides which were then dried, viewed, and results documented by photography. The number of epidermal keratinocytes that contained seven or more grains per 1000 cells viewed was quantitated using an Oncor V-150 computer-assisted image analysis system.
Results
Expression of β 2 integrin molecules by peripheral blood leukocytes isolated from SENCAR mice treated topically with TPA Using flow cytometric analysis, the present study confirms our previous observations that topical application of TPA to the dorsal epidermis of SENCAR mice induces a dose-and timedependent increase in the number of leukocytes within the peripheral blood (4) . Flow cytometric analysis of the anti-β 2 integrin antibody binding by peripheral blood leukocytes revealed that leukocytes isolated from TPA-treated SENCAR mice bound significantly less anti-β 2 integrin antibody than leukocytes isolated from acetone-treated mice (Figure 1 ).
Immunochemical localization of the β 2 integrin family of proteins and ICAM-1 adhesion molecule proteins in cutaneous tissue following topical treatment of SENCAR epidermis with TPA and in papillomas
Immunochemical localization studies were performed to identify cells within the dermis, epidermis and papillomas that express the β 2 integrin family of proteins and ICAM-1 adhesion molecule proteins following topical application of TPA to the dorsal epidermis of SENCAR mice. At 24 h following topical treatment of mouse epidermis with 10 µg TPA, ICAM-1 was expressed by basal and suprabasal keratinocytes, dermal fibroblasts ( Figure 2A ) and endothelial cells ( Figure 2B ). In contrast, there was no visible ICAM-1 protein present in skin treated with acetone ( Figure 2C ). At 24 h following exposure to 10 µg TPA, leukocytes within the dermis bound anti-LFA-1 antibody (Figure 2D ), compared with the very low level of expression of LFA-1 (CD 11a/CD 18) protein by cells in the dermis of acetone treated mice (not shown). The specificity of the antibody-binding was determined by assessment of isotypic control antibody-binding, which was negligible ( Figure 2E ). ICAM-1 protein was present at very high levels within papillomas, which was localized to basal keratinocytes within the proliferative compartment of the papilloma ( Figure 2F ) and was also present on microvascular endothelium ( Figure 2G ). There were numerous leukocytes located within the stromal tissue of papillomas, which stained with both anti-LFA-1 (CD 11a) antibody ( Figure 2H ) and anti-Mac-1 (CD 11b) antibody ( Figure 2I ). The specificity of the antibody-binding was determined by examining the extent to which the isotypic antibody bound, which was negligible ( Figure 2J ). Histological alterations induced by injection of SENCAR mice with β 2 integrin/ICAM-1 adhesion molecule antibodies and treated topically with TPA In skin isolated at 24 h after injection with either of the two isotypic control antibodies, followed at 1 h later by topical treatment with 0.2 ml acetone, the stratum corneum was well defined, the intact epidermis contained 1-2 layers of nucleated cells, and there were few leukocytes within the dermis (Ͻ5 leukocytes per 60ϫ field) ( Figure 3A and B) . In skin isolated at 24 h after injection of either of the two isotypic control antibodies, followed at 1 h later by topical application of 10 µg TPA, there was a significant amount of focal epidermal hyperplasia, with a maximum of 3-6 layers of nucleated cells within the epidermis, as well as a significant increase in the numbers of leukocytes within the dermis (Ͼ50 leukocytes per 60ϫ field). Topical treatment of mouse skin with TPA also induced a 1.5-fold increase in dermal thickening ( Figure 3C and D). Injection of 50 µg anti-β 2 integrin antibody significantly inhibited TPA-induced leukocyte infiltration into the dermis (Ͻ20 leukocytes per 60ϫ field), with leukocytes visible only within the lower portion of the dermis ( Figure 3E ). In contrast, injection of anti-β 2 integrin antibody did not alter the extent of TPA-induced epidermal hyperplasia. Injection of anti-ICAM-1 antibody altered neither TPA-induced epidermal hyperplasia nor TPA-induced leukocyte infiltration into the dermis ( Figure  3F ). Although administration of anti-LFA-1 antibody (CD 11a), anti-Mac-1 antibody (CD 11b) or anti-p150, 95 antibody (CD 11c) inhibited TPA-induced infiltration of leukocytes into the dermis, the inhibitory effect was less than that observed following injection of anti-β 2 (CD 18) integrin antibody. Regardless of the antibody used, there was no effect on TPAinduced epidermal hyperplasia.
Quantitative assessment of the effects of injection of anti-β 2 integrin/ICAM-1 adhesion molecule antibodies on TPA-induced dermal leukocyte infiltration and on MPO produced by leukocytes within the dermis
Leukocyte infiltration into the dermis is a characteristic component of the host response to topical exposure to tumor promoters (2,3). Our laboratory has previously combined antiGr-1 antibody with image analysis to enumerate neutrophils present in the dermis (16) . Injection of either anti-β 2 integrin antibody alone or the combination of anti-β 2 integrin ϩ anti-ICAM-1 antibodies at 1 h prior to topical application of 10 µg TPA significantly inhibited (P Ͻ 0.001) TPA-induced infiltration of Gr-1 ϩ neutrophils into the dermis ( Figure 4A ). Similar results were obtained with i.v. injection of either anti-β 2 integrin antibody alone or the combination of anti-β 2 integrin ϩ anti-ICAM-1 antibodies at 1 h prior to topical application of 2 µg TPA (data not shown). To examine the effect of injection of β 2 integrin/ICAM-1 adhesion molecule antibodies on the production of reactive oxygen intermediates by leukocytes within cutaneous tissue, MPO activity was evaluated. As shown in Figure 4B , i.v. injection of anti-β 2 integrin ϩ anti-ICAM adhesion molecule antibodies significantly (P Ͻ 0.01) inhibited TPA-induced dermal MPO activity.
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Although i.v. injection of anti-β 2 antibody alone also significantly (P Ͻ 0.03) inhibited TPA-induced MPO activity, this effect was not as great as the inhibition of MPO observed with injection of the combination of the two antibodies.
Quantitative assessment of the effects of injection of anti-β 2 integrin/ICAM-1 adhesion molecule antibodies on the presence of TPA-induced epidermal 8-OHdG oxidative DNA adducts
The formation of 8-OHdG adducts has been used as a marker for oxidative DNA damage in response to exposure of murine skin to TPA (28) (29) (30) , DMBA (31, 32) and ultraviolet (UV) light (33) . Quantitation of the number of cells that bound anti-8-OHdG antibody within 10 high power (60ϫ) fields was accomplished using a combination of immunochemistry and quantitative image analysis. Cells that bound anti-8-OHdG antibody were located within the basal, suprabasal and follicular regions in the skin isolated from SENCAR mice injected with isotypic control antibody followed at 1 h by topical treatment with 2 µg TPA ( Figure 5A ). Injection of anti-ICAM-1 adhesion antibody alone or in combination with anti-β 2 integrin antibody at 1 h prior to topical application of 2 µg TPA resulted in a significant reduction in the number of cells that contained 8-OHdG immunoreactive protein (P Ͻ 0.004 anti-ICAM-1 antibody; combination of anti-ICAM-1 ϩ anti-β 2 integrin antibodies P Ͻ 0.001; Figure 5B ). The combination of these two antibodies inhibited formation of 8-OHdG immunoreactive protein in basal cells, suprabasal keratinocytes and follicular cells ( Figure 5B ). There were low but detectable numbers of epidermal and follicular cells that contained 8-OHdG immunoreactive protein in acetone-treated skin ( Figure 5C ). The ability of injection of antibodies directed against adhesion/ integrin molecules to inhibit formation of 8-OHdG oxidative DNA adducts within epidermal cells following topical application of 2 µg TPA correlated with the ability of these antibodies to inhibit both TPA-induced leukocyte infiltration and TPAinduced MPO activity.
Analysis of the effect of injection of β 2 integrin/ICAM-1 adhesion antibodies on epidermal proliferation
Quantitation of proliferating cells within the epidermis isolated at 24 h following injection with anti-β 2 integrin/ICAM-1 adhesion antibodies and topical treatment with TPA was assessed by enumeration of cells that had incorporated [methyl-3 H]thymidine. Cells were defined as being within the proliferative compartment if they contained seven or more silver grains per cell. A total of 1000 cells per section were counted separately in the epidermis. Injection of antibodies directed against either the β 2 integrin family of proteins or the ICAM-1 adhesion molecule did not alter the TPA-induced proliferation of epidermal cells (data not shown).
Discussion
Although inflammation has been used as a hallmark of tumor promotion (2, 3) , the role of leukocytes in this process remains unclear and the molecules that mediate the localization and retention of these cells within the dermis have not been characterized. Previous studies have suggested that the β 2 integrin/ICAM adhesion families of molecules play a role in inflammatory responses in a variety of organ systems, including skin (19) (20) (21) (22) . The present studies are the first to examine the expression of β 2 integrin/ICAM-1 adhesion proteins by specific cells in the skin during TPA-induced cutaneous inflammation and in papillomas that form at later stages of the tumor Fig. 3. (A-F) Histological alterations induced in TPA-treated skin by injection of β 2 integrin/ICAM-1 adhesion molecule antibodies. Skin isolated from SENCAR mice injected with isotypic antibody, followed at 1 h later by topical treatment with acetone, contained an intact epidermis that contained 1-2 layers of nucleated cells, and a well-defined statum corneum with few leukocytes (Ͻ5 cells per 60ϫ field) within the dermis (A and B, respectively). In skin isolated at 24 h after injection of isotypic control antibody, followed at 1 h later by topical application of 10 µg TPA, there were significant numbers of neutrophils within the dermis and significant focal epidermal hyperplasia (C and D, respectively). There was also dermal thickening, an increase in the thickness of the dermal fatty layer and widely dilated vessels within the stroma. Injection of 50 µg anti-β 2 integrin antibody followed at 1 h by topical application of 10 µg TPA inhibited infiltration of neutrophils into the dermis, with leukocytes visible only in the lower dermis (E). Although there was no effect on TPA-induced epidermal hyperplasia, injection of anti-β 2 integrin antibody inhibited TPA-induced dermal thickening. Injection of anti-ICAM-1 antibody followed at 1 h by topical application of 10 µg TPA did not alter either TPA-induced focal epidermal hyperplasia or dermal neutrophil infiltration, with an accumulation of leukocytes at the junction of the dermal-subcutaneous fatty layer (Ͼ20 neutrophils per 60ϫ field) (F). All photographs are 30ϫ magnification.
promotion process following exposure to a DMBA/TPA multistage carcinogenesis protocol. These studies are also the first to determine the ability of antibodies directed against either the individual α subunits (CD 11 a, b and c) or the β 2 subunit (CD 18) of the β 2 integrin family of molecules, or against ICAM-1 adhesion molecule to inhibit specific components of the TPA-induced inflammatory response in the skin.
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The initial studies examined whether β 2 integrin proteins were present on the plasma membranes of peripheral blood leukocytes isolated from mice treated topically with TPA or whether expression of β 2 integrin proteins occurred after leukocytes had undergone transendothelial migration and were localized within the dermis. Although the present results confirm our previous observations demonstrating significantly increased numbers of neutrophils within the systemic circulation at 24 h following topical application of TPA, the present results also show that upregulation of β 2 integrin molecules by neutrophils isolated from TPA-treated mice occurred as a local phenomenon and were expressed at higher levels only after these cells had migrated into the dermis.
One of the hallmarks of TPA-induced skin tumor promotion is the infiltration of leukocytes into the dermis. The present studies demonstrate that injection of anti-β 2 (CD 18) integrin antibody significantly inhibited TPA-induced neutrophil infiltration into the dermis. Although not as effective as injection of anti-β 2 antibody, antibodies directed against the alpha subunits of the β 2 family of integrin molecules, LFA-1 (CD 11a) and Mac-1 (CD 11b), also inhibited directed migration of leukocytes into the dermis induced by topical application of TPA. This is consistent with previous studies that have reported that these two alpha subunits of the β 2 integrin family of molecules contribute to adhesion of neutrophils to endothelial cells (17) . A number of studies have also shown that Mac-1 (CD-11b) mediates neutrophil priming and adherencedependent release of reactive oxygen intermediates by mono-452 Immunochemical localization techniques were combined with quantitative image analysis to assess the effect of injection of anti-β 2 integrin molecule antibody, anti-ICAM-1 molecule antibody or the combination of anti-β 2 integrin ϩ anti-ICAM-1 adhesion molecule antibodies on TPA-induced formation of oxidative DNA adducts. Cutaneous tissue isolated from mice injected i.v. with isotypic control antibody followed at 1 h later by topical application of 2 µg TPA, contained cells that bound anti-8-OHdG antibody located within the basal, suprabasal and follicular regions (A, 30ϫ magnification). There was significantly (P Ͻ 0.001) fewer cells that contained 8-OHdG oxidative DNA adducts in tissue isolated from SENCAR mice that had been injected with the combination of anti-β 2 integrin ϩ anti-ICAM-1 antibodies followed at 1 h by topical application of 2 µg TPA (B, 30ϫ magnification). (C) The low level of anti-8-oxo-dG antibody staining present in skin isolated from SENCAR mice injected i.v. with a combination of rat and hamster IgG isotypic control antibodies followed at 1 h later by topical application of 0.2 ml acetone.
cytes and neutrophils during inflammatory responses (reviewed in Ref. 36 ). Our results indicate that there were significant numbers of cells that express either CD 11a or CD 11b or both of these α subunits of β 2 integrin proteins during TPAinduced cutaneous inflammation and within the stroma of papillomas. Furthermore, these cells were also shown to produce MPO, which is used as a measure of the ability of leukocytes to produce reactive oxygen intermediates (16, (25) (26) (27) . Taken together, these studies suggest that leukocytes within the tumor stroma are localized in proximity to proliferating papilloma cells and that they may contribute to on-going production of reactive intermediates that are known to be involved in induction of genetic alterations associated with tumor promotion and which may be associated with progression of pre-neoplastic lesions to carcinomas. Although these results indicate that both neutrophils and monocytes play a role in both the early and the later stages of tumor promotion, at which point papillomas and carcinomas are present, further studies are required to determine the specific contribution of these two phenotypically and functionally distinct leukocyte populations to the process of multi-stage carcinogenesis.
Topical application of TPA to the dorsal epidermis induces a dramatic infiltration of leukocytes into the dermis, which are activated to produce both reactive oxygen and nitrogen intermediates (4, 34) . Epidermal cells have also been shown to produce hydrogen peroxide and superoxide anion (4, (37) (38) (39) . Although the cell type(s) primarily responsible for the formation of 8-OHdG oxidative DNA adducts present in epidermal keratinocytes during tumor promotion have not yet been identified, the production of the highly mutagenic oxidative DNA adduct 8-OHdG, which occurs due to release of reactive intermediates during tumor promotion, has been well documented (4, (26) (27) (28) (29) (30) (31) (32) 34, (40) (41) (42) (43) . Although our previous studies have demonstrated that leukocytes isolated from TPA-treated mice produce sufficient reactive intermediates to induce mutations in mammalian cells (44) , there are no studies thus far that have demonstrated that TPA-treated epidermal keratinocytes have comparable abilities. Therefore, the relative contributions of leukocytes and epidermal keratinocytes to TPA-induced oxidative damage is not known. Although injection of anti-β2 integrin/ICAM-1 antibodies inhibited migration of neutrophils into the dermis as well as inhibited their ability to produce MPO, the extent of inhibition of these activities was Ͻ50%. Nevertheless, this level of inhibition in numbers and functional activity of leukocytes was sufficient to inhibit formation of oxidative DNA base modifications. The present study is the first to localize 8-OHdG adducts within epidermal and follicular cells during tumor promotion using specific antibodies, and is also the first to demonstrate that oxidative DNA adduct formation within specific epithelial cell populations can successfully be prevented by blockade of β 2 integrin/ ICAM-1 adhesion molecule interactions. Furthermore, the present study indicates that leukocytes may be the cell type that is critical to formation of mutagenic modified DNA bases, such as 8-OHdG, that are present during skin tumor promotion. Without such integrin/adhesion molecule interactions, activated leukocytes do not undergo transendothelial migration and are not present within the local epidermal/dermal milieu, MPO production is significantly diminished, and the formation of 8-OHdG oxidative DNA adducts within epidermal keratinocytes and follicular cells is inhibited.
In addition to upregulation of β 2 integrin molecules on the surface of infiltrating leukocytes, TPA stimulates the expression of ICAM-1 adhesion molecules by dermal endothelial cells, dermal fibroblasts, and by both basal and suprabasal keratinocytes. Antibody directed against ICAM-1 was only partially effective in inhibiting the infiltration of leukocytes into the dermis in response to topical treatment of the epidermis with TPA. The ability of anti-ICAM-1 antibody to partially block entry of leukocytes into the dermis is because of the role of this ligand in the early events of leukocyte-endothelial adhesion, which is required for transendothelial migration to successfully occur. The failure of anti-ICAM-1 antibody to completely block leukocyte emigration into the dermis may be because of the presence of other ligands such as ICAM-2, which can interact with the β 2 integrin family of proteins on the membrane of leukocytes (9, 10) . Alternatively, the lack of complete inhibition of leukocyte infiltration by administration of anti-ICAM-1 antibody may also be caused by a rapid turnover of the receptor/ligand pairs. Based on the present results, the β 2 integrin family of proteins and ICAM-1 adhesion molecules appear to have distinctly different but equally important roles in regulating TPA-induced dermal inflammatory responses. The most effective means of blocking leukocyte migration into the dermis would be to inhibit the interactions between β 2 integrin and ICAM-1 adhesion molecules. Based on the present results, this would result in diminished levels of reactive intermediates in the skin and a subsequent decrease in oxidative DNA adduct formation within epidermal and follicular keratinocytes.
Using various models of inflammation, previous studies have suggested that the ability of leukocytes to migrate and adhere to endothelial cells is dependent upon the presence of cytokines that regulate expression of β 2 integrin/ICAM-1 adhesion molecules (12, 13) . Studies in our laboratory have demonstrated that topical application of TPA to the dorsal skin of SENCAR mice rapidly induces gene expression and protein production of IL-1α and TNF-α, which persist over the course of the tumor-promotion process (14) (15) (16) . Cells that produce IL-1α were identified histochemically as non-proliferating epidermal keratinocytes, dermal fibroblasts, endothelial cells and neutrophils. These cells, as well as monocytes within the dermis, also produce TNF-α. Other studies have demonstrated that IFN-γ acts as a co-promoter with TPA (45), which may be linked to the known ability of IFN-γ to induce expression of β 2 integrin/ICAM-1 adhesion molecules (12, 13) . Further evidence, which suggests that cytokines regulate expression of integrin/adhesion molecules, is based on results of our previous studies, which demonstrated that injection of anti-IL-1α antibodies inhibited infiltration of neutrophils into the dermis (14, 15) . Taken together with the present results that demonstrate that β 2 integrin proteins are expressed by neutrophils within the dermis, these results further indicate that localization and retention of leukocytes within the dermis and at the dermal-epidermal junction during cutaneous inflammation may be dependent upon cytokine release and/or synthesis and release, which would subsequently upregulate expression of β 2 integrin/ICAM-1 adhesion molecule pairs.
Treatment of the dorsal epidermis of SENCAR mice with TPA induces not only a rapid increase in leukocytes within the dermis but also stimulates a dramatic hyperplastic response (1) (2) (3) 5) . Cytokines such as IL-1α, TNF-α and granulocytemacrophage colony-stimulating factor may, at least in part, mediate the epidermal and follicular hyperplasia observed during TPA-induced inflammation and tumor promotion (14) (15) (16) 46) . Our studies have demonstrated that topical treatment of the dorsal epidermis with TPA induces production of pro-inflammatory cytokines by both resident skin cells and infiltrating leukocytes (14) (15) (16) 46) , however, the relative importance of the different cellular sources of these cytokines that drive keratinocyte proliferation following topical application of TPA is not clear. The present observations demonstrate that blockade of leukocyte infiltration into the dermis by injection of antibodies directed against β 2 integrin/ICAM-1 adhesion molecules did not significantly alter TPA-induced epidermal hyperplasia. These results suggest that infiltrating leukocytes are not the primary source of factors that regulate the proliferative responses within the epidermis following topical application of TPA. This observation also implies that cells that reside within the cutaneous tissue, including epidermal keratinocytes, Langerhans cells and dendritic epithelial T cells, i.e. γ/δ T lymphocytes, are the sources of autocrine growth factors that regulate clonal expansion of initiated cells.
Although no previous studies have examined the role of β 2 integrin family of proteins in tumor promotion, previous studies have characterized the phenotype and functions of leukocytes that either reside or infiltrate into the skin under normal conditions and during UV-induced inflammation. These studies demonstrated that injection of anti-LFA-1 (CD 11a) or anti-ICAM-1 antibodies, but not anti-Mac-1 (CD 11b), interfered with the ability of non-UV-irradiated mice to generate a contact sensitivity response (47) . Although injection of anti-Mac-1 (CD 11b) antibodies did not alter the responsiveness to contactsensitizing agents, blockade of UV-induced infiltration of Mac-1ϩ leukocyte populations into the skin, which produce reactive oxygen, resulted in a decrease in the severe damage to the epidermal structure that is present following exposure to UV irradiation. Our current observations expand those made previously in the UV model of skin inflammation and demonstrate that inhibiting migration of β 2 integrin ϩ leukocyte populations not only inhibits formation of reactive oxygen intermediates, measured by MPO activity, but also diminishes the subsequent production of mutagenic oxidatively modified DNA bases in specific epidermal cell populations that are at risk for transformation during multi-stage carcinogenesis.
In summary, the present results suggest that the ability of TPA to induce leukocyte infiltration into the dermis, is, at least in part, related to the induction of expression of β 2 integrin/ ICAM-1 adhesion molecules by cells within the local cutaneous microenvironment. The β 2 integrin/ICAM-1 adhesion molecules regulate interactions between leukocytes and endothelial cells, which allows transendothelial migration of these cells into the dermis. These integrin/adhesion molecules also appear to play a role in functional activation of these cells, leading to production of MPO within the dermis, and results in the formation of 8-OHdG oxidative DNA adducts within specific epidermal and follicular cell populations. These studies also indicate that the use of agents capable of blocking β 2 integrin/ ICAM-1 adhesion molecule interactions may lead to a better understanding of the roles of specific cell populations in multistage carcinogenesis and may also be effective anti-promoting and anti-progression agents.
